Sequenom, Inc. (NASDAQ:SQNM) a life sciences company providing innovative genetic analysis solutions, announced that it has received premarket 510(k) clearance from the United States Food and Drug Administration (FDA) to market its IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx™ System. Sequenom, Inc. (NASDAQ:SQNM) net profit margin is -55.10% and weekly performance is 8.79%. On last trading day company shares ended up $3.34. Analysts mean target price for the company is $4.50. Sequenom, Inc. (NASDAQ:SQNM) distance from 50-day simple moving average (SMA50) is 20.27%.
June 12, 2014 — NewLead Holdings Ltd (NASDAQ:NEWL) announced that on June 3, 2014, NewLead received a Temporary Restraining Order against Ironridge Global IV, Ltd (“Ironridge”) enjoining the issuance of further common shares of NewLead pursuant to its Series A Preference Shares. On June 11, 2014, the United States District Court, Southern District of New York (“Court”) determined that a Preliminary Injunction against such further issuance was unavailable because, as a threshold matter, the Court lacked jurisdiction over Ironridge. NewLead Holdings Ltd (NASDAQ:NEWL) shares fell -26.30% in last trading session and ended the day on $0.442. NewLead Holdings Ltd (NASDAQ:NEWL) quarterly performance is -99.69%.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Fusion-io, Inc. . (NYSE:FIO) concerning the buyout by SanDisk. Under the terms of the agreement, which is valued at approximately $1.1 billion, Fusion shareholders will only receive $11.25 in cash for each share owned, well below the 52-week high of $15.59 and at least one analyst’s estimated value of $16 per share. Fusion-IO, Inc. (NYSE:FIO) shares moved up 22.41% in last trading session and was closed at $11.36, while trading in range of $11.34 – $11.45. Fusion-IO, Inc. (NYSE:FIO) year to date (YTD) performance is 27.50%.
Level 3 Communications, Inc. (NYSE:LVLT) and tw telecom (TWTC) announced that they have entered into a definitive agreement, intended to qualify as a tax-free reorganization, whereby Level 3 will acquire tw telecom in a stock-and-cash transaction valued at $40.86 per share based on market close as of June 13, 2014. Level 3 Communications, Inc. (NYSE:LVLT) ended the last trading day at $42.30. Company weekly volatility is calculated as 3.40% and price to cash ratio as 16.54. Level 3 Communications, Inc. (NYSE:LVLT) showed a negative weekly performance of -1.58%.
Medtronic Inc (NYSE:MDT) bonds were little changed on Monday, despite news that its US$43bn acquisition of Covidien could lead S&P to downgrade its AA- rating. Medtronic, Inc. (NYSE:MDT) net profit margin is 18.00% and weekly performance is -3.55%. On last trading day company shares ended up $60.03. Analysts mean target price for the company is $65.63. Medtronic, Inc. (NYSE:MDT) distance from 50-day simple moving average (SMA50) is -0.11%.
Leave a Reply